Trump Frees Two More Marijuana Prisoners Amid DEA Reschedule Review

September 5, 2026

Photo by JodyDellDavis via Pixabay.

On September 3, 2026, President Trump commuted the sentences of two federal marijuana prisoners, Jerry Haymon IV and Kevin Harden, both of whom had spent years behind bars for cannabis distribution convictions that would draw little more than a business license in a dozen states today. The timing isn't incidental. It lands right as the DEA works through its own rescheduling review, with a recommendation from the administrative law judge overseeing that process expected sometime in late 2026.

Put those two things side by side and an obvious question surfaces: if the federal government is simultaneously admitting marijuana probably doesn't belong in Schedule I, why is relief for people already serving time for it still trickling out one case at a time? Roughly 3,000 people remain in federal custody on marijuana trafficking charges. Two more names added to a commutation list is real, meaningful for the men involved, and nowhere close to a systemic fix.

Who Got Clemency and Why It Took So Long

Jerry Haymon IV was convicted on a marijuana distribution conspiracy charge carrying a 10-year mandatory minimum, the kind of sentence length that predates most states' legalization votes entirely. He'd already spent the last year of his term in home confinement, with roughly another year left when the commutation came through. What made the arrangement particularly galling to advocates watching his case was how restrictive the monitoring conditions were: his home confinement supervisor blocked him from doing social media work for a cannabis company and from participating in research at a drug policy organization, even though neither activity involved him touching, growing, or selling the plant. He was barred from writing and thinking about the industry he'd been imprisoned for participating in.

Kevin Harden's case carried a heavier sentence and a harder physical toll. He was serving part of a 30-year term for conspiracy to distribute marijuana, and during his incarceration he underwent multiple open-heart surgeries, developed a seizure disorder, and dealt with blood clotting complications. His co-defendant, James Romans, had already received clemency from Trump back on the last day of his first term, leaving Harden to keep serving years after his co-conspirator walked free. Notably, Mike Tyson wrote a letter of support for both men's clemency applications, lending some celebrity weight to petitions that otherwise move through a slow, opaque pardon office process.

The Bigger Backlog: Thousands Still Serving Time

Photo by sergeitokmakov via Pixabay.

Two commutations look small next to the scale of who's still locked up. U.S. Sentencing Commission data puts the number of people federally incarcerated specifically for marijuana trafficking offenses at roughly 3,000, and a meaningful share of them are serving mandatory minimums of five years or longer, sentences handed down under drug quantity thresholds that haven't been revisited even as state markets built around the same plant now generate billions in legal tax revenue.

In May 2026, a coalition of Democratic lawmakers sent a letter to Trump and to Alice Marie Johnson, the White House's pardon czar, pushing for something categorical rather than another round of individual petitions: a blanket commutation mechanism that could move through the backlog in one action instead of requiring each prisoner's family or legal team to assemble a clemency application and hope it catches attention.

The comparison to Biden's record is instructive here. Biden's mass pardons, issued during his term, covered simple possession offenses but explicitly excluded people convicted of selling or distributing cannabis, the exact population Haymon and Harden came out of. That carve-out meant the population with the longest sentences and the most severe legal consequences never got the benefit of a mass action at all. Advocates tracking this issue have been blunt about the math: at two names per commutation announcement, clearing a backlog measured in the thousands would take years, if it happens at all.

Where Rescheduling Actually Stands

The rescheduling process actually moving through the federal bureaucracy right now traces back to Executive Order 14370, which directed the government to expedite its review of marijuana's scheduling status. Acting on that mandate, Acting Attorney General Todd Blanche moved on April 23 and 24, 2026 to place FDA-approved marijuana-derived drugs and state-licensed medical marijuana programs into Schedule III, a partial step that left recreational and unlicensed cannabis exactly where it's always been: Schedule I, alongside heroin, legally speaking the most dangerous and least medically useful category of controlled substance.

That partial move set up a full rescheduling hearing before the DEA, which ran from June 29 through July 15, 2026. DEA's own post-hearing brief argued for moving marijuana to Schedule III across the board, a notable position given that DEA has historically been the agency most resistant to loosening cannabis restrictions.

Administrative Law Judge Derek Julius is now tasked with issuing a formal recommendation based on that hearing record, but his recommendation isn't binding. The final decision rests with DEA Administrator Terrance C. Cole, who can accept, modify, or reject it outright. That recommendation is expected sometime in late 2026, which means as of this clemency news, full rescheduling still hasn't taken effect anywhere in the country. The recreational market, and most of the medical market outside state-licensed programs, remains governed by Schedule I law today.

Why Clemency and Rescheduling Are Getting Tangled Together

Photo by 12019 via Pixabay.

The May 2026 lawmakers' letter didn't treat commutations and rescheduling as separate issues. It explicitly argued that granting clemency to marijuana prisoners was the logical next step given the administration's own rescheduling push. It's hard to argue marijuana deserves Schedule III treatment going forward while people sit in federal prison for conduct that treatment would functionally decriminalize.

But rescheduling and clemency solve genuinely different problems, and it's worth being precise about that distinction. Even if DEA finalizes a move to Schedule III by year's end, that change would not retroactively free a single person convicted under Schedule I trafficking law. Rescheduling adjusts future prosecutions, research access, and how the DEA treats manufacturing and distribution going forward. It does nothing to unwind a sentence someone is already serving. Only executive clemency, case by case or categorical, or new legislation passed by Congress can actually reach back and address people already convicted.

It's also worth flagging that none of this touches state law directly. Legality still varies enormously by state and country, and moving marijuana to Schedule III federally would not legalize recreational marijuana at the federal level, nor would it override any particular state's own possession or distribution laws. Anyone trying to figure out their own legal exposure, whether they're a patient, a grower, or a business owner, should check current law in their specific state or country rather than assume a DEA scheduling change resets anything for them personally.

Two commutations are two commutations. Real relief for Haymon and Harden, and worth acknowledging as such. But set against roughly 3,000 people still doing federal time for marijuana trafficking, the pace of piecemeal clemency suggests the administration is choosing the slow path over the categorical one lawmakers put in front of it back in May. Nothing so far indicates that's about to change.

Rescheduling won't fill that gap either, even in the best case where DEA finalizes a Schedule III move by the end of the year. That action changes what happens to people prosecuted from here forward. It does nothing for people already sentenced under the old rules, and closing that gap requires either an act of clemency or an act of Congress, neither of which has arrived at the scale the backlog demands.

The two markers actually worth watching now are procedural rather than political: Administrative Law Judge Derek Julius's recommendation and whatever Administrator Terrance C. Cole ultimately decides to do with it. Those two decisions, expected before the year is out, will say more about whether 2026 becomes the year federal cannabis policy actually moved than any single commutation announcement will.